Haruo Miyata

Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial

Chie Oshita, Masako Takikawa, Akiko Kume et al. · Oncology Reports · 2012 · 103 citations · Full text

Medicine, Immunology, Oncology +17

Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse

Tadashi Ashizawa, Akira Iizuka, Chizu Nonomura et al. · Clinical Cancer Research · 2016 · 102 citations

Medicine, Immunology, Oncology +17

Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma

Tadashi Ashizawa, Haruo Miyata, Akira Iizuka et al. · International Journal of Oncology · 2013 · 97 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Yasuto Akiyama, Chie Oshita, Akiko Kume et al. · BMC Cancer · 2012 · 85 citations · Full text

Medicine, Immunology, Oncology +15

Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse

Tadashi Ashizawa, Akira Iizuka, Emiko Tanaka et al. · Biomedical Research · 2019 · 54 citations · Full text

Medicine, Oncology, Pharmacology +17